Free fatty acids | Controls | HCV pretreatment patients | HCV post treatment patients |
---|---|---|---|
C – 14:0 | 1.5 ± 0.6 | 2.0 ± 1.1 | 2.0 ± 0.5 |
C - 16 : 0 | 23.8 ± 3.6a | 28.6 ± 5.9b | 25.8 ± 2.5c |
C - 18 : 0 | 10.8 ± 4.1a | 14.4 ± 5.4b | 10.2 ± 1.7a |
C - 20 : 0 | 0.5 ± 0.9 | 0.6 ± 2.1 | 1.6 ± 1.1 |
C - 14 : 1 | 0.1 ± 0.3a | NDb | 0.2 ± 0.4c |
C - 16 : 1 | 2.8 ± 1.4 | 3.5 ± 1.5 | 3.8 ± 1.2 |
C - 18 : 1 | 20.7 ± 2.9 | 19.9 ± 3.9 | 21.6 ± 2.1 |
C - 22 : 1 | 2.2 ± 1.3 | 2.2 ± 1.3 | 2.8 ± 1.0 |
C - 18 : 2 | 29.9 ± 4.6a | 21.2 ± 4.6b | 23.8 ± 5.6c |
C - 18 : 3 | 0.4 ± 1.1 | 0.2 ± 0.6 | 0.4 ± 0.7 |
C - 20 : 4 | 6.1 ± 1.6a | 4.4 ± 1.4b | 5.3 ± 0.9c |
C - 20 : 5 | 1.0 ± 1.6a | 0.4 ± 0.9b | NDc |
C - 20 : 3 | 0.2 ± 0.7 | 0.1 ± 0.5 | 0.5 ± 1.3 |